1 BioTelemetry Analyst Ratings, Earnings, Dividends and Insider Trades | $BEAT | NASDAQ:BEAT | Analyst Ratings Network

Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

BioTelemetry Company Profile (NASDAQ:BEAT)

Consensus Ratings for BioTelemetry (NASDAQ:BEAT) (?)
Ratings Breakdown: 2 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $13.77 (56.08% upside)

Analysts' Ratings History for BioTelemetry (NASDAQ:BEAT)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/16/2014Dougherty & CoReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
4/1/2014TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
3/18/2014ZacksDowngradeOutperform -> Neutral$12.30ViewTweet This Rating  Share This Rating on StockTwits
2/17/2014ZacksUpgradeNeutral -> Outperform$9.20ViewTweet This Rating  Share This Rating on StockTwits
2/3/2014Benchmark Co.Reiterated RatingBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
12/10/2013ZacksDowngradeOutperform -> Neutral$9.00ViewTweet This Rating  Share This Rating on StockTwits
12/4/2013Benchmark Co.Reiterated RatingBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
12/4/2013Dougherty & CoReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
11/11/2013ZacksUpgradeNeutral -> Outperform$11.80ViewTweet This Rating  Share This Rating on StockTwits
10/24/2013Benchmark Co.Initiated CoverageBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
9/5/2013Lake Street CapitalInitiated CoverageBuy$14.00ViewTweet This Rating  Share This Rating on StockTwits
8/23/2013ZacksDowngradeNeutral$8.60ViewTweet This Rating  Share This Rating on StockTwits
8/21/2013Dougherty & CoInitiated CoverageBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/23/2012 forward)